课题基金 / 基金详情

Simulation of Coronary Artery Bypass Graft and Surgical Ventricular Restoration

Simulation of Coronary Artery Bypass Graft and Surgical Ventricular Restoration
冠状动脉搭桥术和心室修复手术的模拟
批准号:
7915279
负责人:
Julius Matteo Guccione
金额:
$76.23万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-15 至 2011-07-31
关键词:
3-DimensionalAccountingAddressAdoptedAdultAffectAlgorithmsAnatomic structuresAnatomyAnterior Descending Coronary ArteryAortaArchitectureAreaArteriesAutomobile DrivingAwarenessBiologicalBiologyBiomechanicsBiomedical ComputingBiomedical EngineeringBiomedical ResearchBiophysicsBlood VesselsBlood capillariesBlood flowBypassCardiacCardiac Surgery proceduresCardiovascular systemCellsCerealsCerebral PalsyCessation of lifeChemicalsChildCodeCollaborationsCollectionCommunitiesComplementComputer AssistedComputer SimulationComputer softwareComputer-Aided DesignCopyrightCoronaryCoronary ArteriosclerosisCoronary Artery BypassCoronary arteryCustomDataData AnalysesData SetDatabasesDevelopmentDevice DesignsDisciplineDiseaseDoctor of MedicineDocumentationDrug Delivery SystemsDyskinetic syndromeElectrophysiology (science)ElectrostaticsElementsEngineeringEnsureEnvironmentEpidemicEquationEvaluationFiberFigs - dietaryFutureGenerationsGenetic MedicineGoalsGrantHeartHeart failureHumanImageImageryIndianaIndividualInfarctionInterventionInvestigationLaboratoriesLanguageLeadLeftLeft Ventricular FunctionLeft Ventricular RemodelingLettersLibrariesLicensingLifeLinkLiquid substanceLocationLogicMagnetic Resonance ImagingMathematicsMechanicsMedicalMedical DeviceMedical ResearchMedical centerMethodologyMethodsMissionModelingModificationMolecularMotionMovementMuscleMuscle CellsMyocardialMyocardial IschemiaMyopathyMyosin ATPaseNational Center for Research ResourcesNatureNewsletterNonmuscle Myosin Type IIBOperative Surgical ProceduresOrganOrganismPaperParkinson DiseasePatient CarePatientsPatternPerformancePersonsPharmaceutical PreparationsPhilosophyPhysicsPhysiologicalPhysiologyPostoperative PeriodProblem SolvingProceduresProcessProsthesis DesignPublic DomainsRNARNA FoldingRandomizedResearchResearch InfrastructureResearch PersonnelResourcesRunningScientistSelection CriteriaSimulateSoftware EngineeringSoftware ToolsSolidSolutionsSourceSource CodeStrokeStructureSurgeonSystemTechniquesTechnologyTechnology TransferTestingTimeTissuesTrainingTreesUnited StatesUnited States National Institutes of HealthUniversitiesValidationVascular DiseasesVascular SystemVentricularWorkadvanced simulationbasebiological systemsbiomedical scientistbody systemcapillarycommercializationcomputer sciencecomputerized toolsdata modelingdesigndisease diagnosisdissemination researcheffective therapyfluid flowgraduate studentgraphical user interfacehemodynamicsimage visualizationimprovedinnovationinterestleft coronary arterymacromoleculemathematical modelmembermetermillimetermodels and simulationnanometerneuromuscularnovelnovel strategiesopen sourcepalliationpatient populationphysical propertypressureprogramsrandomized trialrepositoryresponserestorationshear stresssimulationsoftware developmenttooltool development

项目摘要

项目成果

Julius Matteo Guccione的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart failure has reached epidemic proportions in the United States and is responsible for nearly 500,000 deaths each year. The majority of heart failure cases is now the result of infarction- induced left ventricular (LV) remodeling. The lack of a well-established effective treatment has lead to a continually expanding list of medical and surgical options for the palliation of heart failure patients. Coronary artery bypass grafting (CABG) and surgical ventricular restoration (SVR) are the two surgical options included in the ongoing $38 million NIH-sponsored multi- center randomized STICH trial (to be completed in 2008). Another recently completed randomized trial has shown for the first time a benefit of CABG + SVR over CABG alone in patients with heart failure caused by coronary artery disease. Moreover, it confirms that the SVR procedure can be performed safely in patients with severely reduced LV function. Broad, Long-Term Objective: Develop and validate a public-domain software tool that will enable clinicians to easily simulate the effects of CABG and SVR on patients with ischemic heart failure. Specific Aims: 1. Develop physics-based simulations of CABG and SVR using only public-domain software. 2. Perform pre- and post-operative CT and MRI exams on STICH patients in order to quantify their LV wall geometry and function and coronary artery anatomy and blood flow distribution. 3. Validate the simulations in Aim #1 using the LV function and coronary blood flow data acquired in Aim #2. In addition, as part of a repository for wide dissemination to the user community, CABG and SVR models will be made available via the simulation tool kit (SimTK) of Stanford's National Center for Physics-Based Simulation of Biological Structures (Simbios). These models and tools will complement work that is ongoing as part of one of the Simbios driving biological problems lead by Dr. Charley Taylor that focuses on blood flow and grafts in the aorta, and will provide a larger repertoire of fluid flow modeling capabilities in SimTK.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10741-016-9528-9
发表时间: 2016-11
期刊: Heart failure reviews
影响因子: 4.6
作者: [Sack KL, Davies NH, Guccione JM, Franz T]
通讯作者: Franz T
DOI: 10.1016/j.jbiomech.2009.08.042
发表时间: 2010-01-19
期刊: Journal of biomechanics
影响因子: 2.4
作者: [Chen HY, Navia JA, Shafique S, Kassab GS]
通讯作者: Kassab GS
DOI: 10.1371/journal.pone.0073769
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Huo Y, Luo T, Guccione JM, Teague SD, Tan W, Navia JA, Kassab GS]
通讯作者: Kassab GS
DOI: 10.1007/s10439-012-0579-3
发表时间: 2012-10
期刊: ANNALS OF BIOMEDICAL ENGINEERING
影响因子: 3.8
作者: [Sankaran, Sethuraman, Moghadam, Mahdi Esmaily, Kahn, Andrew M., Tseng, Elaine E., Guccione, Julius M., Marsden, Alison L.]
通讯作者: Marsden, Alison L.
Multi-Scale Laws of Myocardial Growth and Remodeling
Multi-Scale Laws of Myocardial Growth and Remodeling
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure
海外基金